Use of neurofilament-light chain (NfL) in the management of patients with multiple sclerosis

June 27, 2024

Recommend to a Colleague print

 

Summarizes recent guidance on the use of NfL in clinical practice. Includes management algorithms published by Freedman et al. eBioMedicine 2024;101:104970.

8 slides

Download the slide deck

Recommend to a Colleague

Related Posts

• AAN 2025 – report on fluid biomarkers in MS
  April 22, 2025
• AAN DAILY HIGHLIGHTS – WEDNESDAY, APRIL 9, 2025
  April 9, 2025
• AAN DAILY HIGHLIGHTS – TUESDAY, APRIL 8, 2025
  April 8, 2025
• ACTRIMS Forum 2025: Update on biomarkers
  March 17, 2025
• ACTRIMS Forum 2025 Highlights – Saturday, March 1, 2025
  March 1, 2025

Go back to home page